Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > EV / EBITDA (ltm)

Arbutus Biopharma Cp EV / EBITDA (ltm) Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly EV / EBITDA (ltm) from 2019 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Arbutus Biopharma Cp Market Cap for the quarter ending March 03, 2018 was $275m a 28.06% increase of 77m year over year
  • Arbutus Biopharma Cp Price / Book for the quarter ending March 03, 2018 was 2.07 a 49.51% increase of 1.03 year over year
  • Arbutus Biopharma Cp Enterprise Value for the quarter ending March 03, 2018 was $211m a 52.69% increase of 111m year over year
View Chart On Koyfin